LONDON STRATEGIC HEALTH AUTHORITY
4TH FLOOR, SOUTHSIDE, 105 VICTORIA STREET, LONDON, GREATER LONDON, SW1E 6QT See member list for this organisation
CHD 14
The percentage of patients with a history of myocardial infarction (from 1 April 2011) currently treated with an ACE inhibitor (or ARB if ACE intolerant), aspirin or an alternative anti-platelet therapy, beta blocker and statin (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CHD 11 | 2007 | 17172 | 18893 | 90.9% | |
| CHD 11 | 2008 | 20325 | 22466 | 90.5% | |
| CHD 11 | 2009 | 23237 | 25809 | 90.0% | |
| CHD 11 | 2010 | 25690 | 28506 | 90.1% | |
| CHD 11 | 2011 | 29436 | 32839 | 89.6% | |
| CHD 14 | 2012 | 4146 | 4492 | 92.3% |
